Suretest Australia

WANTAI SARS-COV-2 Rapid Antigen Test (RAT) is a lateral flow immunofluorescent assay (FIA) intended for screening of high risk individuals for the COVID-19 virus, using nasopharyngeal (NP) and oropharyngeal (OP) swab specimens. Our RAT kits are included in the Australian Register of Therapeutic Goods 345191. Suretest was founded by Dr Peter Lewis, an internationally recognised regenerative medicine physician. As the Medical Director of Surecell, Dr Lewis treats patients, trains medical professionals from across the globe and hosts monthly public seminars at his Malvern clinic. Contact us on 03 8547 3685 or info@suretest.com.au!